Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017
Amy Zalin‐Miller(National Health Service), Shahid A. Khan(Imperial College London), Craig Knott(Insight Healthcare), Lizz Paley, Mireille B. Toledano(St Mary's Hospital), Helen Morement(CRUK Lung Cancer Centre of Excellence), Daniela Tataru(National Health Service), Sophie Jose(Insight Healthcare)
Cited by 9
Related Papers
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Cholangiocarcinoma
|The Lancet|2005|1.1k
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
|Journal of Hepatology|2002|592